Pepgen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.85

+0.44 (+18.26%)

As of Aug 8, 2:01 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 1 7%

Sell 1 7%

Price Target

Analyst Price Target +1,267.4% upside

Low Target $29.17

Average Target $38.97

High Target $44.78

Current Price $2.85

Current
$2.85

Target
$38.97

$29.17 $38.97 avg $44.78

Scenario Analysis

Bear Case

$29.17

923.5%

Low target

Base Case

$38.97

+1,267.4%

Avg target

Bull Case

$44.78

+1,471.2%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$7.80

-63.5% from high

52-Week Low

$1.01

+182.2% from low

Target vs 52W High

$38.97

+399.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%